Aurobindo Pharma Limited has informed the Exchange regarding a press release dated January 31, 2025, titled "CuraTeQ Biologics s.r.o, receives positive opinion from CHMP / EMA for Dyrupeg".
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated January 31, 2025, titled "CuraTeQ Biologics s.r.o, receives positive opinion from CHMP / EMA for Dyrupeg".